Indications for TPM insertion
AV node dysfunction, n (%)
Sinus Node Dysfunction, n (%)
Ventricular arrhythmia, n (%)
|
33 (52.4%)
24 (38.1%)
6 (9.5%)
|
32 (50.8%)
26 (41.3%)
5 (7.9%)
|
P=0.911
|
Vein Access
Subclavian, n (%)
Internal jugular, n (%)
Femoral, n (%)
|
2 (3.2%)
20 (31.7%)
41 (65.1%)
|
56 (89.0%)
7 (11.1%)
0 (0%)
|
P<0.001
|
Permanent pacemaker, n (%) |
36 (57.1%) |
35 (55.5%) |
P=0.857 |
Serious cardiovascular events* after TPM
insertion, n (%) |
6 (9.5%) |
1 (1.5%) |
P= 0.075 |
* Including cardiogenic shock, new myocardial
infarction, and new fatal ventricular arrhythmia
AV- Atrioventricular, TPM- Temporary pacemaker
|
* Including cardiogenic shock, new myocardial
infarction, and new fatal ventricular arrhythmia
AV- Atrioventricular, TPM- Temporary pacemaker
|
* Including cardiogenic shock, new myocardial
infarction, and new fatal ventricular arrhythmia
AV- Atrioventricular, TPM- Temporary pacemaker
|
* Including cardiogenic shock, new myocardial
infarction, and new fatal ventricular arrhythmia
AV- Atrioventricular, TPM- Temporary pacemaker
|